Frizzled-2: A potential novel target for molecular pancreatic cancer therapy
Minoru Tomizawa1, Fuminobu Shinozaki2, Takao Sugiyama3
1Department of Gastroenterology, National Hospital Organization, Shimoshizu Hospital, Yotsukaido, Chiba 284-0003, Japan.
Abstract:
In the present study, pancreatic cancer cell proliferation was analyzed following the suppression of frizzled (Fz)2 expression. Reverse transcription polymerase chain reaction (PCR) was performed using RNA isolated from pancreatic cancer cell lines, PANC-1, NOR-P1, PK-45H, PK-1, PK-59, MIA-Paca2 and KP4. A surgical specimen of pancreatic cancer was immunostained with antibodies specific to Fz2. Cell proliferation assays were performed with MIA-Paca2 cells transfected with small interfering RNA (siRNA) or short hairpin RNA (shRNA) of Fz2. Fz2 was found to be expressed in all pancreatic cancer cell lines, with the exception of NOR-P1. Immunostaining revealed that Fz2 was not expressed in normal pancreatic tissues, while it was expressed in pancreatic cancer cells. The expression levels of cyclin D1 were analyzed by quantitative PCR. The proliferation and expression of cyclin D1 were suppressed with the siRNA and shRNA of Fz2 in the MIA-Paca2 cells. Therefore, Fz2 is a potential target for the molecular therapy of pancreatic cancer.
Insights
Frizzled (Fz)2 is expressed in pancreatic cancer cells but not normal tissue. Suppressing Fz2 inhibited cancer cell proliferation and cyclin D1 expression, indicating its potential as a molecular therapy target.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Pancreatic cancer is a leading cause of cancer-related deaths.
- Identifying novel molecular targets is crucial for effective pancreatic cancer therapy.
- Frizzled (Fz)2, a receptor in the Wnt signaling pathway, has been implicated in various cancers.
Purpose of the Study:
- To investigate the role of Frizzled (Fz)2 expression in pancreatic cancer cell proliferation.
- To determine if Fz2 could serve as a potential therapeutic target for pancreatic cancer.
Main Methods:
- Reverse transcription polymerase chain reaction (RT-PCR) and quantitative PCR (qPCR) were used to analyze Fz2 and cyclin D1 gene expression in pancreatic cancer cell lines and surgical specimens.
- Immunohistochemistry was performed on pancreatic cancer tissues to assess Fz2 protein expression.
- Cell proliferation assays were conducted using MIA-Paca2 cells transfected with small interfering RNA (siRNA) or short hairpin RNA (shRNA) targeting Fz2.
Main Results:
- Frizzled (Fz)2 was expressed in most pancreatic cancer cell lines tested, but not in normal pancreatic tissues.
- Fz2 expression was detected in pancreatic cancer cells within surgical specimens.
- Suppression of Fz2 using siRNA and shRNA led to decreased proliferation of MIA-Paca2 cells.
- Fz2 suppression also resulted in reduced expression of cyclin D1, a key regulator of cell cycle progression.
Conclusions:
- Frizzled (Fz)2 is overexpressed in pancreatic cancer and plays a significant role in promoting cancer cell proliferation.
- Fz2 is a potential molecular target for the development of novel therapeutic strategies against pancreatic cancer.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...